November 20, 2024 at 1:42 pm
Forte Biosciences Secures $53 Million to Fast-Track Breakthrough Autoimmune Therapy; Stock Soars 137%
Forte Biosciences, Inc. (NASDAQ: FBRX), a clinical-stage biopharmaceutical company specializing in autoimmune diseases, has raised $53 million in an oversubscribed private placement. The funds will… [Read More]